Atara Biotherapeutics

-$0.30 (-2.30%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATRA and other ETFs, options, and stocks.

About ATRA

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219.

CEO

Pascal Touchon

Employees

437

Headquarters

South San Francisco, California

Founded

2012

ATRA Key Statistics

Market Cap

1.13B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

577.84K

High Today

$13.05

Low Today

$12.69

Open Price

$12.90

Volume

567.46K

52 Week High

$28.20

52 Week Low

$11.33

Analyst Ratings

90%

of 10 ratings

Buy

90%

Hold

Sell

10%

ATRA Earnings

-$1.41

-$0.94

-$0.47

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 13, After Hours